Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II) - Ye, Qingsong; Wang, Hua; Xia, Xia; Zhou, Chenliang; Liu, Zhiming; Xia, Zun-en; Zhang, Zhan; Zhao, Yang; Yehenala, Jun; Wang, Si; Zhou, Gangqiao; Hu, Ke; et al. (Current controlled trials in cardiovascular medicine, 2020)
Keywords: Adolescent; Adult; Aged; Blood platelets; Blood pressure; Cholesterol; Clinical trials; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Coronaviruses; COVID-19; COVID-19 - therapy; COVID-19; randomised controlled trial; protocol; human dental pulp stem cells; dental stem cell banking; Cytokines; Cytomegalovirus; Dental pulp; Dental Pulp - cytology; Female; Hepatitis; Hospitalization; Humans; Intensive care; Laboratories; Letter; Lipoproteins; Lymphocytes; Male; Middle Aged; Neutrophils; Outcome Assessment, Health Care; Patients; Pneumonia; Proteins; Randomized Controlled Trials as Topic; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Stem Cell Transplantation - adverse effects; Stem Cell Transplantation - methods; Stem cells; Transplantation, Homologous; Ventilators; Young Adult; COVID-19; randomised controlled trial; protocol; human dental pulp stem cells; dental stem cell banking